|
|
||||||||
|
FIGURE 2. Individual kidney absorbed dose of 90Y-DOTATOC, using 86Y-DOTATOC quantitative imaging. MIRDOSE3.1 was used for dosimetric calculations. Data are reported for males (n = 9) and females (n = 9). The continuous line represents median kidney dose in each group. Filled circles represent patients with CLR loss per year >20%.
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |